EPB41L4B anticorps (AA 351-450) (FITC)

N° du produit ABIN1710228

Cet anticorps anti-EPB41L4B est un anticorps Lapin Polyclonal détectant EPB41L4B dans WB, IF (cc) et IF (p). Adapté pour Souris.

Aperçu rapide pour EPB41L4B anticorps (AA 351-450) (FITC) (ABIN1710228)

Antigène: EPB41L4B (erythrocyte Membrane Protein Band 4.1 Like 4B (EPB41L4B))

Reactivité: Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp EPB41L4B est conjugé à/à la FITC

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Détail du produit anti-EPB41L4B anticorps (FITC)

Épitope: AA 351-450

Réactivité croisée: Souris

Homologie: Human,Rat,Dog,Cow,Sheep,Horse

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human EHM2

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur EPB41L4B

Antigène: EPB41L4B (erythrocyte Membrane Protein Band 4.1 Like 4B (EPB41L4B))

Autre désignation: EHM2

Sujet:

Synonyms: Band 4.1 like protein 4B, Band 4.1-like protein 4B, CG1, DKFZp761N1814, E41LB_HUMAN, EHM 2, EPB41L4B, Erythrocyte membrane protein band 4.1 like 4B, FERM containing protein, FERM containing protein CG1, FERM-containing protein CG1, FLJ21596, OTTHUMP00000021883, OTTHUMP00000021884, Protein EHM2.

Background: EHM2 belongs to the NF2/ERM/4.1 superfamily of proteins, which function in connecting cell surface transmembrane proteins to cytoskeletal molecules.